mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis-Reference-Cited by-同舟云学术

mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis

Published:2015-07-01 Issue:1 Volume:16 Page:
ISSN:1471-2369
Container-title:BMC Nephrology
language:en
Short-container-title:BMC Nephrol

Author:

Xie Xishao,Jiang Yan,Lai Xiuxiu,Xiang Shilong,Shou Zhangfei,Chen Jianghua

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/article/10.1186/s12882-015-0078-5/fulltext.html

Reference38 articles.

1. Marcen R. Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection. Drugs. 2009;69:2227–43.

2. Hardinger KL, Brennan D. Novel immunosuppressive agents in kidney transplantation. World J Transplant. 2013;3:68.

3. Knight SR, Russell NK, Barcena L, et al. Mycophenolate Mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with Azathioprine: a systematic review. Transplantation. 2009;87:785–94.

4. Maripuri S, Kasiske BL. The role of mycophenolate mofetil in kidney transplantation revisited. Transplant Rev (Orlando). 2014;28:26–31.

5. Budde K, Curtis J, Knoll G, et al. Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: Results of a 1-year study. Am J Transplant. 2004;4:237–43.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bexarotene Induce Differentiation of Myeloid-Derived Suppressor Cells through Arg-1 Signalling Pathway;Transplantation Proceedings;2024-07

2. Effectiveness and safety of immunosuppressive regimens used as maintenance therapy in kidney transplantation: The CESIT study;PLOS ONE;2024-01-02

3. Renal function at 12 months of kidney transplantation comparing tacrolimus and mycophenolate with tacrolimus and mTORi in donors with different KDPI ranges. A multicenter cohort study using propensity scoring;Frontiers in Transplantation;2023-10-16

4. New Perspectives in Cytomegalovirus After Transplant: The Role of Immunosuppressant Management;Transplantation;2023-04-13

5. A systematic review and meta-analysis comparing everolimus and calcineurin inhibitors (CNIs) to mycophenolate and CNIs in kidney transplant patients;Korean Journal of Transplantation;2023-03-31